Laurion Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Laurion Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-219,000	Closed	-$3.12M	–	900
2019 Q1	$3.12M	Buy	+219,000	New	+$2.03M	0.14%	267

Other funds holding AXSM

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return